Gastric inhibitory polypeptide

GIP is derived from a 153-amino acid proprotein encoded by the GIP gene and circulates as a biologically active 42-amino acid peptide. It is synthesized by K cells, which are found in the mucosa of the duodenum and the jejunum of the gastrointestinal tract.{{cite book|title=Physiology| vauthors = Costanzo L |publisher=Saunders/Elsevier|year=2014|isbn=9781455708475|location=Philadelphia, PA|pages=337}}

Like all endocrine hormones, it is transported by blood.

Gastric inhibitory polypeptide receptors are seven-transmembrane proteins (GPCRs) found on beta-cells in the pancreas.

It has traditionally been named gastrointestinal inhibitory peptide or gastric inhibitory peptide and was found to decrease the secretion of stomach acid{{cite journal | vauthors = Kim W, Egan JM | title = The role of incretins in glucose homeostasis and diabetes treatment | journal = Pharmacological Reviews | volume = 60 | issue = 4 | pages = 470–512 | date = December 2008 | pmid = 19074620 | pmc = 2696340 | doi = 10.1124/pr.108.000604 }} to protect the small intestine from acid damage, reduce the rate at which food is transferred through the stomach, and inhibit the GI motility and secretion of acid. However, this is incorrect, as it was discovered that these effects are achieved only with higher-than-normal physiological level, and that these results naturally occur in the body through a similar hormone, secretin.{{cite journal | vauthors = Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W | title = Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects | journal = Digestion | volume = 52 | issue = 3–4 | pages = 214–221 | date = 1992 | pmid = 1459356 | doi = 10.1159/000200956 }}

It is now believed that the function of GIP is to induce insulin secretion, which is stimulated primarily by hyperosmolarity of glucose in the duodenum.{{cite journal | vauthors = Thorens B | title = Glucagon-like peptide-1 and control of insulin secretion | journal = Diabete & Metabolisme | volume = 21 | issue = 5 | pages = 311–318 | date = December 1995 | pmid = 8586147 }} After this discovery, some researchers prefer the new name of glucose-dependent insulinotropic peptide, while retaining the acronym "GIP." The amount of insulin secreted is greater when glucose is administered orally than intravenously.{{cite book | vauthors = Boron WF, Boulpaep EL | title = Medical physiology: a cellular and molecular approach | year = 2009 | publisher = Saunders/Elsevier | location = Philadelphia, PA | isbn = 9781416031154 | edition = 2nd International }}

In addition to its role as an incretin, GIP is known to inhibit apoptosis of the pancreatic beta cells and to promote their proliferation. It also stimulates glucagon secretion and fat accumulation. GIP receptors are expressed in many organs and tissues including the central nervous system enabling GIP to influence hippocampal memory formation and regulation of appetite and satiety.{{cite journal | vauthors = Seino Y, Fukushima M, Yabe D | title = GIP and GLP-1, the two incretin hormones: Similarities and differences | journal = Journal of Diabetes Investigation | volume = 1 | issue = 1–2 | pages = 8–23 | date = April 2010 | pmid = 24843404 | pmc = 4020673 | doi = 10.1111/j.2040-1124.2010.00022.x }}

GIP recently appeared as a major player in bone remodeling. Researchers at Universities of Angers and Ulster evidenced that genetic ablation of the GIP receptor in mice resulted in profound alterations of bone microarchitecture through modification of the adipokine network.{{cite journal | vauthors = Gaudin-Audrain C, Irwin N, Mansur S, Flatt PR, Thorens B, Baslé M, Chappard D, Mabilleau G | title = Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in mice | journal = Bone | volume = 53 | issue = 1 | pages = 221–230 | date = March 2013 | pmid = 23220186 | doi = 10.1016/j.bone.2012.11.039 | url = http://eprints.uthm.edu.my/8086/1/Dr._Sity_Aishah.pdf | access-date = 2018-11-20 | url-status = dead | s2cid = 36280105 | archive-url = https://web.archive.org/web/20180721091447/http://eprints.uthm.edu.my/8086/1/Dr._Sity_Aishah.pdf | archive-date = 2018-07-21 }} Furthermore, the deficiency in GIP receptors has also been associated in mice with a dramatic decrease in bone quality and a subsequent increase in fracture risk.{{cite journal | vauthors = Mieczkowska A, Irwin N, Flatt PR, Chappard D, Mabilleau G | title = Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality | journal = Bone | volume = 56 | issue = 2 | pages = 337–342 | date = October 2013 | pmid = 23851294 | doi = 10.1016/j.bone.2013.07.003 | s2cid = 19296511 | url = https://hal.univ-angers.fr/hal-03262094/file/2013b-bone.pdf }} However, the results obtained by these groups are far from conclusive because their animal models give discordant answers and these works should be analysed very carefully.{{cn|date=May 2022}}

It has been found that type 2 diabetics are not responsive to GIP and have lower levels of GIP secretion after a meal when compared to non-diabetics.{{cite journal | vauthors = Skrha J, Hilgertová J, Jarolímková M, Kunešová M, Hill M | title = Meal test for glucose-dependent insulinotropic peptide (GIP) in obese and type 2 diabetic patients | journal = Physiological Research | volume = 59 | issue = 5 | pages = 749–755 | year = 2010 | pmid = 20406045 | doi = 10.33549/physiolres.931893 | doi-access = free }} In research involving knockout mice, it was found that absence of the GIP receptors correlates with resistance to obesity.{{cite journal | vauthors = Yamada Y, Seino Y | title = Physiology of GIP--a lesson from GIP receptor knockout mice | journal = Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et Metabolisme | volume = 36 | issue = 11–12 | pages = 771–774 | year = 2004 | pmid = 15655707 | doi = 10.1055/s-2004-826162 | s2cid = 262453421 }}

{{reflist|30em}}

• {{MeshName|Gastric+inhibitory+polypeptide}}
• {{cite web | vauthors = King MW | title = Gastrointestinal Hormones and Peptides | url = http://web.indstate.edu/thcme/mwking/peptide-hormones.html#gastrin | date = 16 November 2006 | publisher = Indiana University – Purdue University Indianapolis School of Medicine | archive-url = https://web.archive.org/web/20071206035951/http://web.indstate.edu/thcme/mwking/peptide-hormones.html#gastrin | archive-date = 6 December 2007 | url-status = dead | access-date = 1 October 2006 }}
• {{PDBe-KB2|P09681|Gastric inhibitory polypeptide}}

{{Hormones}}

{{Gastrointestinal physiology}}

{{Neuropeptides}}

Category:Gastroenterology

Category:Intestinal hormones

Category:Diabetes